Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

copper Cu 64 FBP8

A radioconjugate consisting of fibrin binding probe 8 (FBP8), a fibrin-targeting cyclic peptide, labeled with the radioisotope copper Cu 64, which may be used to image fibrin upon positron emission tomography (PET)/magnetic resonance (MR) imaging. Upon administration of copper Cu 64 FBP8, the FBP8 moiety selectively targets and binds to fibrin. This allows for visualization of fibrin-containing thrombus and emboli upon PET/MR imaging and may help in the diagnosis of arterial thrombosis, deep vein thrombosis (DVT) and pulmonary embolism (PE).

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	[64Cu]FBP8 64Cu-FBP8 copper-64 labeled fibrin binding probe 8

copper Cu 64 FBP8

Search NCI's Drug Dictionary